FDA Orange Book
Is there a generic for Invega Trinza?
Invega Trinza contains paliperidone palmitate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Invega Trinza (paliperidone palmitate). The Orange Book shows its last listed patent expires April 5, 2036.
Run it in Rivvi
Map Invega Trinza and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Invega Trinza products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| suspension, extended release, intramuscular | 273MG/0.875ML (273MG/0.875ML) | Marketed (Rx) | None | 0 | None |
| suspension, extended release, intramuscular | 410MG/1.315ML (311.79MG/ML) | Marketed (Rx) | None | 0 | None |
| suspension, extended release, intramuscular | 546MG/1.75ML (312MG/ML) | Marketed (Rx) | None | 0 | None |
| suspension, extended release, intramuscular | 819MG/2.625ML (312MG/ML) | Marketed (Rx) | None | 0 | None |
NDA 207946, held by JANSSEN PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Invega Trinza patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 10143693 | April 5, 2036 | Method of use | U-2458 | 207946 |
| 10143693 | April 5, 2036 | Method of use | U-2457 | 207946 |
Invega Trinza NDC codes
Questions
Is there a generic for Invega Trinza?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Invega Trinza (paliperidone palmitate). The Orange Book shows its last listed patent expires April 5, 2036.
What is the generic name for Invega Trinza?
The active ingredient in Invega Trinza is paliperidone palmitate, per the FDA Orange Book.
When does the Invega Trinza patent expire?
The last patent listed for Invega Trinza in the Orange Book expires April 5, 2036. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Invega Trinza and Paliperidone Palmitate
- What is Invega Trinza used for?FDA label uses
- Is Invega Trinza a controlled substance?Federal schedule
- Generic for ErzofriFDA Orange Book
- Generic for Invega HafyeraFDA Orange Book
- Generic for Invega SustennaFDA Orange Book
- Atypical Antipsychotics listFDA drug class
- NDC 50458-606Invega Trinza NDC record
- NDC 50458-607Invega Trinza NDC record
- NDC 50458-608Invega Trinza NDC record